Aurobindo Pharma

Phone: +9140 6672 5000 / 6672 1200

Fax: +91 (40) 2374 1080 / +91 (40) 2374 6833

E-mail: info@aurobindo.com

Web: https://www.aurobindo.com

Type	Public
Traded as	NSE: AUROPHARMA BSE: 524804
Industry	Pharmaceuticals
Founded	1986
Founders	V. Ramprasad Reddy K. Nityananda Reddy
Headquarters	Hyderabad, Telangana, India
Products	Pharmaceuticals generic drugs over-the-counter drugs vaccines diagnostics contact lenses animal health
Revenue	₹23,290 crore (US$2.9 billion) (2020)
Operating income	₹4,063 crore (US$510 million) (2020)
Net income	₹2,844 crore (US$360 million) (2020)
Total assets	₹28,926 crore (US$3.6 billion) (2020)
Total equity	₹16,751 crore (US$2.1 billion) (2020)
Number of employees	23,000 (2020)
Website	www.aurobindo.com

Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.

For detailed contact information visit location pages below.